Vishal Sikri
Presidente en Inivata Ltd. .
Fortuna: 2 M $ al 30/04/2024
Perfil
Vishal Sikri is currently the President & Chief Commercial Officer at Inivata Ltd.
He previously worked as the President-Advanced Diagnostics at NeoGenomics, Inc. from 2022 to 2024.
Mr. Sikri has an undergraduate degree from Beloit College, an MBA from Loyola University of Chicago, and a graduate degree from the University of Wisconsin.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NEOGENOMICS, INC.
0.10% | 25/03/2024 | 129 085 ( 0.10% ) | 2 M $ | 30/04/2024 |
Cargos activos de Vishal Sikri
| Empresas | Cargo | Inicio |
|---|---|---|
Inivata Ltd.
 Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Presidente | 23/05/2022 |
Antiguos cargos conocidos de Vishal Sikri.
| Empresas | Cargo | Fin |
|---|---|---|
| NEOGENOMICS, INC. | Corporate Officer/Principal | 15/04/2024 |
Formación de Vishal Sikri.
| Beloit College | Undergraduate Degree |
| University of Wisconsin | Graduate Degree |
| Loyola University of Chicago | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NEOGENOMICS, INC. | Health Services |
| Empresas privadas | 1 |
|---|---|
Inivata Ltd.
Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
- Bolsa de valores
- Insiders
- Vishal Sikri
